Healio

Exposure to cholinergic compounds, personal care products may lead to early puberty

Please provide your email address to receive an email when new articles are posted on . Musk ambrette, found in some personal care products, increased stimulating activity in kisspeptin receptor cells ...
Healio

FDA approves first new class of schizophrenia treatment in more than 30 years

Please provide your email address to receive an email when new articles are posted on . Cobenfy is the first antipsychotic medication to treat schizophrenia by targeting cholinergic receptors. The ...
Becker's Hospital Review

FDA approves schizophrenia treatment

The medication, formerly known as KarXT, is the first antipsychotic medication to target cholinergic receptors rather than dopamine receptors, according to a Sept. 26 news release from the agency.
Medscape

FDA OKs First-in-Class Antipsychotic for Schizophrenia

The US Food and Drug Administration (FDA) has approved Cobenfy (Bristol Myers Squibb), a first-in-class antipsychotic approved for schizophrenia. The drug targets cholinergic receptors as opposed to ...
Seeking Alpha

Bristol-Myers wins FDA nod for first-of-its-kind antipsychotic

The U.S. Food and Drug Administration (FDA) on Thursday approved Cobenfy (xanomeline and trospium chloride), developed by Bristol-Myers Squibb (NYSE:BMY), as a novel treatment for adults with the ...